What Happened?
Watertown, MA-based Tectonic-Therapeutic Appointed Alise Reicin as Chief Executive Officer and President
About the Company
Tectonic, co-founded by Andrew Kruse and Tim Springer of Harvard Medical School, is transforming the discovery of antibodies and other biologic drugs targeting G-protein Coupled Receptors (GPCRs). With our proprietary GEODe™ platform, we are targeting the most difficult, previously undruggable receptors in the class, aiming to unlock their therapeutic utility to develop new treatments for a broad range of patients with important unmet needs.
About the Person
Alise Reicin is Chief Executive Officer and President at Tectonic Therapeutic. Previously, Alise held various senior HR leadership roles in the industry.
Info Source
News
Short Profile